Hadassah

Liver Disease Early Diagnosis Device Developed at Hadassah Medical Center Receives Exemption from FDA, Providing Fast Track for Approval

Monday, Oct 24 2011

Liver Disease Early Diagnosis Device Developed at Hadassah Medical Center Receives Exemption from FDA, Providing Fast Track for Approval

BreathID, a noninvasive early diagnosis device for acute liver failure developed at the Hadassah University Medical Center, has obtained a United States Food and Drug Administration (FDA) Humanitarian Device Exemption, which provides a fast-track toward approval. Prof. Yaron Ilan, Director of Hadassah's Department of Internal Medicine A is Medical Director of BreathID's developer, Exalenz Bioscience Ltd., a startup company of Hadasit, Hadassah's technology transfer arm.

The device, as well as saving lives through early diagnosis, can lead to the elimination of unnecessary liver transplants. The humanitarian use device (HUD) designation which BreathID received means that the device does not have to undergo an efficacy trial, thereby greatly shortening the approval process if it meets FDA requirements. BreathID's effectiveness in diagnosing acute liver failure was demonstrated in a trial of several dozen patients at Hadassah and London's Kings College.
The FDA has already approved a clinical trial of the BreathID device for the early diagnosis of Hepatocellular Carcinoma, a liver cancer.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Jan 16 2019

Hadassah Hospital Ein Kerem Receives Award for Premature Babies

Our Hadassah stars! The staff at Hadassah Hospital Ein Kerem was awarded the “Outstanding Pagination” Award in the Ministry of Health’s 2018 Star Program.

READ MORE ›
alt_text

Monday, Jan 14 2019

When Arms Don’t Match: Hadassah Surgeon Repairs Complex Long-term Injury

Oshry was two years old when his father broke his arm the first time. The second time, social services got involved.

READ MORE ›
alt_text

Wednesday, Jan 9 2019

Creative “Magic Tricks” Reduce Need to Sedate Kids for Radiation Treatment

Until recently, kids in Israel with cancer were almost always sedated for radiation treatment. At the Hadassah Medical Organization, however, that is changing.

READ MORE ›
alt_text

Monday, Jan 7 2019

From Surviving a Terror Attack to the Birth of a New Baby

Three and a half years ago, Inbar and Ori Azrak were returning from a romantic weekend in Jerusalem when a terrorist threw a Molotov cocktail into their car.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More